AlgoRx Pharmaceuticals

PharmaceuticalsSeries CSecaucus, US

Latest round

Series C

Last raised

Feb 2004

Total raised

$65M

Investors

14

About AlgoRx Pharmaceuticals

Based US, AlgoRx Pharmaceuticals is drug manufacturer company manufacturing pain killers including ALGRX 4975, which treats postsurgical pain or PowderJect Dermal Lidocaine, a needle-free anesthetic and a topical local anesthetic that could treat chronic pain.

Who invested in AlgoRx Pharmaceuticals

14 investors across 1 round

See all investors in AlgoRx Pharmaceuticals

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series C

    Feb 24, 2004

    Amount

    $65M

    Investors

    Locked

Questions about AlgoRx Pharmaceuticals

Who invested in AlgoRx Pharmaceuticals?

AlgoRx Pharmaceuticals has 14 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has AlgoRx Pharmaceuticals raised?

AlgoRx Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did AlgoRx Pharmaceuticals last raise money?

AlgoRx Pharmaceuticals's most recent round on record is a Series C, in Feb 2004.

What does AlgoRx Pharmaceuticals do?

Based US, AlgoRx Pharmaceuticals is drug manufacturer company manufacturing pain killers including ALGRX 4975, which treats postsurgical pain or PowderJect Dermal Lidocaine, a needle-free anesthetic and a topical local anesthetic that could treat chronic pain.

Where is AlgoRx Pharmaceuticals headquartered?

AlgoRx Pharmaceuticals is headquartered in Secaucus, US.

Which VCs invest in companies like AlgoRx Pharmaceuticals?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at AlgoRx Pharmaceuticals's stage. Their profiles are linked below.

Raising like AlgoRx Pharmaceuticals? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.